Received Apr 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No evidence of immunity to measles or varicella.; No evidence of immunity to measles or varicella.; Caller reported that patient had their bone marrow completely reconstituted during leukemia treatment resulting in lack of immunity. / boosters of VARIVAX in 2013 and MMR-II in 2015 following leukemia treatments.; This spontaneous report was received from a physician, regarding a 17-year-old patient of unknown gender. The patient's medical history and concomitant medication were not reported. Concurrent conditions included Leukemia (in remission). On 2008, the patient was vaccinated with a dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), at a dose of 0.5 mL as prophylaxis in combination with sterile diluent. And also on the same year, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), also at a dose of 0.5 ml as prophylaxis in combination with sterile diluent (strengths, doses, schemes, routes and anatomical locations of administration, lot numbers and expiration dates were not reported). Then on 2013, the patient received a booster of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) and on 2015 a booster of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), this following leukemia treatment. On an unspecified date, they ran titers on the patient for measles, mumps, rubella, and varicella. There was evidence of immunity to mumps and rubella, but no evidence of immunity to measles or varicella. Caller reported that patient had their bone marrow completely reconstituted during leukemia treatment resulting in lack of immunity. The outcome of the events was not provided. No symptoms reported. The causal relationship between the events and suspect vaccines was not provided.
Leukemia (On remission)
Test Name: measles antibody test; Test Result: Negative ; Test Name: Varicella antibody; Test Result: Negative